Barthel, F. P., K. C. Johnson, F. S. Varn, A. D. Moskalik, G. Tanner, E. Kocakavuk, K. J. Anderson, O. Abiola, K. Aldape, K. D. Alfaro, D. Alpar, S. B. Amin, D. M. Ashley, P. Bandopadhayay, J. S. Barnholtz-Sloan, R. Beroukhim, C. Bock, P. K. Brastianos, D. J. Brat, A. R. Brodbelt, A. F. Bruns, K. R. Bulsara, A. Chakrabarty, A. Chakravarti, J. H. Chuang, E. B. Claus, E. J. Cochran, J. Connelly, J. F. Costello, G. Finocchiaro, M. N. Fletcher, P. J. French, H. K. Gan, M. R. Gilbert, P. V. Gould, M. R. Grimmer, A. Iavarone, A. Ismail, M. D. Jenkinson, M. Khasraw, H. Kim, M. C. M. Kouwenhoven, P. S. LaViolette, M. Li, P. Lichter, K. L. Ligon, A. K. Lowman, T. M. Malta, T. Mazor, K. L. McDonald, A. M. Molinaro, D. H. Nam, N. Nayyar, H. K. Ng, C. Y. Ngan, S. P. Niclou, J. M. Niers, H. Noushmehr, J. Noorbakhsh, D. R. Ormond, C. K. Park, L. M. Poisson, R. Rabadan, B. Radlwimmer, G. Rao, G. Reifenberger, J. K. Sa, M. Schuster, B. L. Shaw, S. C. Short, P. A. S. Smitt, A. E. Sloan, M. Smits, H. Suzuki, G. Tabatabai, E. G. Van Meir, C. Watts, M. Weller, P. Wesseling, B. A. Westerman, G. Widhalm, A. Woehrer, W. K. A. Yung, G. Zadeh, J. T. Huse, J. F. De Groot, L. F. Stead, R. G. W. Verhaak and G. Consortium (2019). "Longitudinal molecular trajectories of diffuse glioma in adults." Nature 576(7785): 112-120.
Bortolomeazzi, M., M. R. Keddar, L. Montorsi, A. Acha-Sagredo, L. Benedetti, D. Temelkovski, S. Choi, N. Petrov, K. Todd, P. Wai, J. Kohl, T. Denner, E. Nye, R. Goldstone, S. Ward, G. A. Wilson, M. Al Bakir, C. Swanton, S. John, J. Miles, B. Larijani, V. Kunene, E. Fontana, H. T. Arkenau, P. J. Parker, M. Rodriguez-Justo, K. K. Shiu, J. Spencer and F. D. Ciccarelli (2021). "Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts." Gastroenterology.
Brandner, S., A. McAleenan, C. Kelly, F. Spiga, H. Y. Cheng, S. Dawson, L. Schmidt, C. L. Faulkner, W. Christopher, S. Jefferies, J. P. T. Higgins and K. M. Kurian (2021). "MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review." Neuro Oncol.
Broz, P., P. Pelegrin and F. Shao (2020). "The gasdermins, a protein family executing cell death and inflammation." Nat Rev Immunol 20(3): 143-157.
Chen, Z., T. Wu, Z. Yan and M. Zhang (2021). "Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma." Front Cell Dev Biol 9: 652599.
Friedlander, A. M. (1986). "Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process." J Biol Chem 261(16): 7123-7126.
Gibson, E. M. and M. Monje (2021). "Microglia in Cancer Therapy-Related Cognitive Impairment." Trends Neurosci 44(6): 441-451.
Guan, X., C. Zhang, J. Zhao, G. Sun, Q. Song and W. Jia (2018). "CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas." EBioMedicine 35: 233-243.
Hodi, F. S., J. D. Wolchok, D. Schadendorf, J. Larkin, G. V. Long, X. Qian, A. Saci, T. C. Young, S. Srinivasan, H. Chang, H. Tang, M. Wind-Rotolo, J. I. Rizzo, D. G. Jackson and P. A. Ascierto (2021). "TMB and Inflammatory Gene Expression Associated With Clinical Outcomes Following Immunotherapy in Advanced Melanoma." Cancer Immunol Res.
Huang, D., J. Chen, L. Yang, Q. Ouyang, J. Li, L. Lao, J. Zhao, J. Liu, Y. Lu, Y. Xing, F. Chen, F. Su, H. Yao, Q. Liu, S. Su and E. Song (2018). "NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death." Nat Immunol 19(10): 1112-1125.
Kay, C., R. Wang, M. Kirkby and S. M. Man (2020). "Molecular mechanisms activating the NAIP-NLRC4 inflammasome: Implications in infectious disease, autoinflammation, and cancer." Immunol Rev 297(1): 67-82.
Kayagaki, N., I. B. Stowe, B. L. Lee, K. O'Rourke, K. Anderson, S. Warming, T. Cuellar, B. Haley, M. Roose-Girma, Q. T. Phung, P. S. Liu, J. R. Lill, H. Li, J. Wu, S. Kummerfeld, J. Zhang, W. P. Lee, S. J. Snipas, G. S. Salvesen, L. X. Morris, L. Fitzgerald, Y. Zhang, E. M. Bertram, C. C. Goodnow and V. M. Dixit (2015). "Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling." Nature 526(7575): 666-671.
Keane, L., M. Cheray, K. Blomgren and B. Joseph (2021). "Multifaceted microglia - key players in primary brain tumour heterogeneity." Nat Rev Neurol 17(4): 243-259.
Lin, W., Y. Chen, B. Wu, Y. Chen and Z. Li (2021). "Identification of the pyroptosisrelated prognostic gene signature and the associated regulation axis in lung adenocarcinoma." Cell Death Discov 7(1): 161.
Louis, D. N., A. Perry, G. Reifenberger, A. von Deimling, D. Figarella-Branger, W. K. Cavenee, H. Ohgaki, O. D. Wiestler, P. Kleihues and D. W. Ellison (2016). "The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary." Acta Neuropathol 131(6): 803-820.
Louis, D. N., A. Perry, P. Wesseling, D. J. Brat, I. A. Cree, D. Figarella-Branger, C. Hawkins, H. K. Ng, S. M. Pfister, G. Reifenberger, R. Soffietti, A. von Deimling and D. W. Ellison (2021). "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary." Neuro Oncol 23(8): 1231-1251.
Mischel, P. S. and T. F. Cloughesy (2003). "Targeted molecular therapy of GBM." Brain Pathol 13(1): 52-61.
Molinaro, A. M., J. W. Taylor, J. K. Wiencke and M. R. Wrensch (2019). "Genetic and molecular epidemiology of adult diffuse glioma." Nat Rev Neurol 15(7): 405-417.
Pirozzi, C. J. and H. Yan (2021). "The implications of IDH mutations for cancer development and therapy." Nat Rev Clin Oncol.
Samstein, R. M., C. H. Lee, A. N. Shoushtari, M. D. Hellmann, R. Shen, Y. Y. Janjigian, D. A. Barron, A. Zehir, E. J. Jordan, A. Omuro, T. J. Kaley, S. M. Kendall, R. J. Motzer, A. A. Hakimi, M. H. Voss, P. Russo, J. Rosenberg, G. Iyer, B. H. Bochner, D. F. Bajorin, H. A. Al-Ahmadie, J. E. Chaft, C. M. Rudin, G. J. Riely, S. Baxi, A. L. Ho, R. J. Wong, D. G. Pfister, J. D. Wolchok, C. A. Barker, P. H. Gutin, C. W. Brennan, V. Tabar, I. K. Mellinghoff, L. M. DeAngelis, C. E. Ariyan, N. Lee, W. D. Tap, M. M. Gounder, S. P. D'Angelo, L. Saltz, Z. K. Stadler, H. I. Scher, J. Baselga, P. Razavi, C. A. Klebanoff, R. Yaeger, N. H. Segal, G. Y. Ku, R. P. DeMatteo, M. Ladanyi, N. A. Rizvi, M. F. Berger, N. Riaz, D. B. Solit, T. A. Chan and L. G. T. Morris (2019). "Tumor mutational load predicts survival after immunotherapy across multiple cancer types." Nat Genet 51(2): 202-206.
Schonberg, D. L., D. Lubelski, T. E. Miller and J. N. Rich (2014). "Brain tumor stem cells: Molecular characteristics and their impact on therapy." Mol Aspects Med 39: 82-101.
Shi, J., Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, Y. Zhuang, T. Cai, F. Wang and F. Shao (2015). "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death." Nature 526(7575): 660-665.
Tan, G., C. Huang, J. Chen and F. Zhi (2020). "HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway." J Hematol Oncol 13(1): 149.
Tirosh, I. and M. L. Suva (2018). "Dissecting human gliomas by single-cell RNA sequencing." Neuro Oncol 20(1): 37-43.
Valero, C., M. Lee, D. Hoen, A. Zehir, M. F. Berger, V. E. Seshan, T. A. Chan and L. G. T. Morris (2021). "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase." JAMA Oncol 7(5): 739-743.
Wang, Y., B. Yin, D. Li, G. Wang, X. Han and X. Sun (2018). "GSDME mediates caspase-3-dependent pyroptosis in gastric cancer." Biochem Biophys Res Commun 495(1): 1418-1425.
Wu, D., R. Han, S. Deng, T. Liu, T. Zhang, H. Xie and Y. Xu (2018). "Protective Effects of Flagellin A N/C Against Radiation-Induced NLR Pyrin Domain Containing 3 Inflammasome-Dependent Pyroptosis in Intestinal Cells." Int J Radiat Oncol Biol Phys 101(1): 107-117.
Xia, X., X. Wang, Z. Cheng, W. Qin, L. Lei, J. Jiang and J. Hu (2019). "The role of pyroptosis in cancer: pro-cancer or pro-"host"?" Cell Death Dis 10(9): 650.
Xuan, W., M. S. Lesniak, C. D. James, A. B. Heimberger and P. Chen (2021). "Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms." Trends Immunol 42(4): 280-292.
Yang, F., Y. Qin, J. Lv, Y. Wang, H. Che, X. Chen, Y. Jiang, A. Li, X. Sun, E. Yue, L. Ren, Y. Li, Y. Bai and L. Wang (2018). "Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy." Cell Death Dis 9(10): 1000.
Ye, Y., Q. Dai and H. Qi (2021). "A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer." Cell Death Discov 7(1): 71.
Zhang, C., W. Cheng, X. Ren, Z. Wang, X. Liu, G. Li, S. Han, T. Jiang and A. Wu (2017). "Tumor Purity as an Underlying Key Factor in Glioma." Clin Cancer Res 23(20): 6279-6291.
Zhang, M., Y. Zheng, Y. Sun, S. Li, L. Chen, X. Jin, X. Hou, X. Liu, Q. Chen, J. Li, M. Liu, X. Zheng, Y. Zhang, J. Wu and B. Yu (2019). "Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome." Theranostics 9(12): 3425-3442.
Zhang, P., L. Cao, R. Zhou, X. Yang and M. Wu (2019). "The lncRNA Neat1 promotes activation of inflammasomes in macrophages." Nat Commun 10(1): 1495.
Zhao, B. and W. Ma (2021). "Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma." Lancet Oncol 22(8): e345.
Zhuo, S., Z. Chen, Y. Yang, J. Zhang, J. Tang and K. Yang (2020). "Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma." Front Oncol 10: 590861.